GNLX

2.1704.82%
YY

Yong Yu

Chief Scientific Officer

Dr. Tony Yu, also known as Tony, Ph.D. serves as Chief Scientific Officer at Genelux Corporation since 2026 and was its Senior Vice President of Clinical Development at Clinical Trial Operations since July 2023 until 2026. Dr. Yu served as Vice President of Clinical Trial Operations at Genelux Corporation since January 2010 and served as its Associate Vice President of Preclinical Research & Business Development from 2008 to 2010. Dr. Yu was an integral part of the initial scientific research that led to the formation of Genelux Corporation. From 2002 to 2008, Dr. Yu was Director of the Imaging Group and Director of Tumor Diagnosis/Therapy. As Director of Tumor Diagnosis & Therapy, Dr. Yu manages preclinical research and interacts with the clinical trials team and the patent attorneys. He received a PhD in anatomy and biochemistry in 2002 from Loma Linda University and a BA in Biology from the University of Utah in 1995.

Positions